T1	intervention 0 33	Partial lower axillary dissection
T2	eligibility 38 90	patients with clinically node-negative breast cancer
T4	intervention-participants 537 541	1043
T5	control 547 566	historical controls
T6	control-participants 610 614	1084
T7	outcome 622 636	5-year overall
T8	outcome 641 668	disease-free survival rates
T9	iv-bin-percent 674 679	95.6%
T10	cv-bin-percent 684 689	89.7%
T11	iv-bin-percent 695 700	94.9%
T12	cv-bin-percent 705 710	88.4%
T14	iv-cont-mean 852 860	41.6 min
T15	cv-cont-mean 868 876	60.9 min
T16	outcome 879 904	intraoperative blood loss
T17	iv-cont-mean 906 913	28.0 ml
T18	cv-cont-mean 922 929	51.3 ml
T19	outcome 932 987	volume of lymphatic drainage at 2 weeks postoperatively
T20	iv-cont-mean 989 995	488 ml
T21	cv-cont-mean 1003 1009	836 ml
T22	outcome 1016 1042	persistent arm lymphoedema
T23	iv-bin-percent 1044 1048	0.0%
T24	cv-bin-percent 1056 1061	11.8%
T13	outcome 826 850	Mean duration of surgery
